Journals / Dicle Tıp Dergisi / 2009 / Cilt: 36 - Sayı: 2

Nosocomial urinary tract infections and resistance profile to antibiotics

Hastane kökenli üriner sistem infeksiyonları ve antibiyotik direnç profili

Pages
85–90
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, high rate resistance was found in bacterial microorganism, especially in Pseudomonas spp.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to investigate the risk factors, laboratuary results, distrubition of pathogens and sensitivity to antibiotics in patients with hospital acquired urinary tract infections (HAUTI). 161 HAUTI patients were diagnosed.
📊
Key Findings & Data:The most commom pathogens isolated were Escherichia coli 33 (29.5 %), Pseudomonas spp. 32 (28.6 %) and Klebsiella spp. 12 (10.7 %).
💡
Conclusion & Impact:As a result, high rate resistance was found in bacterial microorganism, especially in Pseudomonas spp.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study is to investigate the risk factors, laboratuary results, distrubition of pathogens and sensitivity to antibiotics in patients with hospital acquired urinary tract infections (HAUTI). 161 HAUTI patients were diagnosed. The most common predisposing factors were identified as long term hospitalization, urinary catheterization, hospitalization at intensive care unit and neurologic diseases. The most commom pathogens isolated were Escherichia coli 33 (29.5 %), Pseudomonas spp. 32 (28.6 %) and Klebsiella spp. 12 (10.7 %). The lowest rates of resistance in E.coli, Pseudomonas spp. and Klebsiella spp. were observed to amikacin (respectively 3 %, 9 %, 8 %), to imipenem (9 %, 41 %, 8 %), to piperacilin/tazobactam (PIP/TAZ) (24 %, 47 %, 17 %) and to ciprofloxasin (52 %, 69 %, 25 %). Mortality was detected in 31(19%) of 161 patients diagnosed with HAUTI. As a result, high rate resistance was found in bacterial microorganism, especially in Pseudomonas spp.

Özet

Hastane kökenli üriner sistem infeksiyonu (HKÜSİ) en sık görülen hastane kökenli infeksiyon (HKİ)’dur. Hastane kökenli üriner sistem infeksiyonu (HKÜSİ) tanısı ile izlenen hastalarda risk faktörleri, laboratuvar bulguları, etkenlerin dağılımı ve antibiyotik duyarlılıklarının incelenmesi amaçlanmıştır. Çalışma periyodunda 161 HKÜSİ olgusu tesbit edilmiştir. Hastanede uzun yatış, üriner kateter, cerrahi girişim, yoğun bakımda yatış ve nörolojik hastalık en sık predispozan faktörler olarak tesbit edilmiştir. HKÜSİ’da en sık izole edilen etkenler Escherichia coli 33 (% 29.5), Pseudomonas spp. 32 (% 28.6) ve Klebsiella spp. 12 (% 10.7) olarak saptanmıştır. Çalışmamızda E.coli, Pseudomonas spp. ve Klebsiella spp. suşlarına en düşük direnç amikasin (sırasıyle % 3, % 9, % 8), imipenem (% 9, % 41, % 8), piperasilin/tazobaktam (PİP/TAZ) (% 24, % 47, % 17) ve siprofloksasinde (52 %, 69 %, 25 %) gözlenmiştir. HKÜSİ tanısı ile izlenen 161 hastanın 31 (% 19)’inde mortalite saptandı. Sonuç olarak Başta Pseudomonas spp olmak üzere bakteriyel etken mikroorganizmalarda yüksek oranda direnç saptanmıştır.

🔖

Cite This Article

NAZ, H., ÇEVİK, F. Ç., AYKIN, N. (2009). Nosocomial urinary tract infections and resistance profile to antibiotics. Dicle Tıp Dergisi, Cilt: 36 - Sayı: 2, 85–90. https://ajindex.com/articles/349223

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Girard R, Mazoyer MA, Plauchu MM, et al. High prevalence of nosocomial infections in rehabilitation units accounted for by urinary tract infections in patients with spinal cord injury. J Hosp Infect 2006;62:473-9
  2. Haley RW, Culver DH, White JW, et al. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985;121:159–67
  3. Leblebicioglu H, Esen S; Turkish Nosocomial Urinary Tract Infection Study Group. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study. J Hosp Infect 2003;53(3):207-10
  4. Warren JW. Nosocomial urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005.p. 3370-3381 5. Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis 2004;36:144-8
  5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 12th Informational Supplement. 2002 M100-S12, NCCLS. Wayne PA
  6. Garner JS, Jarwis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40
  7. Al-Helali NS, Al-Asmary SM, Abdel-Fattah MM, et al. Epidemiologic study of nosocomial urinary tract infections in Saudi military hospitals. Infect Control Hosp Epidemiol. 2004;25:1004-7
  8. Nguyen-Van-Tam SE, Nguyen-Van-Tam JS, Myint S, et al. Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: a case-control study. Infection 1999;27:192-7
  9. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol 1985;121:182-205
  10. Fadel R, Dakdouki GK, Kanafani ZA, et al. Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon. Infect Control Hosp Epidemiol 2004;25:52-5
  11. Farrell DJ, Morrissey I, De Rubeis D, et al. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100
  12. Savaş L, Güvel S, Turunç T, et al. Toplum kökenli ve nozokomiyal üriner sistem enfeksiyonu etkenleri ve antibiyotik duyarlılıklarının karşılaştırılması. Türk Ürol Derg 2003;29:95-100
  13. Mathai D, Jones RN, Pfaller MA; SENTRY Parti